Sale Ends Tonight! 25% OFF and Free Overnight Shipping!
Must use promo code THANKS2024 at check-out
(Semaglutide) Injection: Wegovy is a brand-name version of the generic medication semaglutide, which is a type of medication called a GLP-1.
Wegovy is a brand-name version of the generic medication semaglutide, which is a type of medication called a glucagon-like peptide 1 receptor agonist. Instead of that tongue-twister of a name, we call these medications “GLP-1s” for short.
Wegovy is FDA-approved and clinically proven to help with weight loss. How? It acts like a natural hormone your body uses to regulate blood sugar and appetite—key steps in resetting your biological set point to help you maintain a new, lower weight. In fact, the STEP 4 clinical trial saw people who combined Wegovy with lifestyle changes lose an average of 10.6% of their body weight after 20 weeks, and 17% after 68 weeks.
Wegovy works by mimicking the GLP-1 hormone, which regulates appetite and blood sugar levels. It helps reduce hunger and prolongs the feeling of fullness, leading to decreased calorie intake. By slowing down gastric emptying and enhancing insulin release, Wegovy aids in weight loss and helps control blood sugar levels in individuals with obesity or overweight conditions.
Additional Details:
All medications carry a risk of potential side effects. Wegovy’s side effects are typically mild and often improve within the first few weeks of treatment. When they occur, it’s usually when doses are increased, then tend to improve once a steady dose is reached. Some of the most common side effects include:
More severe side effects are rarer but possible. Serious side effects include:
Please see the full Prescribing Information, including the BOXED WARNING, for complete safety information.
People lost an average of 14.9% (up to 20%) bodyweight in a 68-week clinical study of Wegovy® (semaglutide).
People lost an average of over 20% bodyweight in a 72-week clinical trial study of tirzepatide*
Wegovy, a form of semaglutide, falls under GLP-1s, a class of medications proven to aid weight loss. By mimicking a natural hormone that regulates blood sugar and appetite, it helps reset your body's weight set point. In clinical trials, those using Wegovy alongside lifestyle changes lost an average of 10.6% of body weight in 20 weeks and 17% in 68 weeks.
Our medication is conveniently delivered from a state-licensed pharmacy within our network, straight to your door when you need it. Each pharmacy conducts third-party testing through FDA and DEA registered labs, ensuring quality control for every compounded lot prescribed to Good Life patients. These tests focus on four key characteristics to guarantee quality and safety.
Passed
Passed
Passed
Passed
Your treatment starts with a small, once-weekly injection to help your body adjust while gently reducing appetite.
Take your injection on the same day each week. The process is quick, simple, and easy to integrate into your schedule.
Every 4 weeks, your dose will increase according to your titration plan, ensuring your body adjusts comfortably while optimizing results.
With consistent use, you’ll experience steady weight loss. Combined with healthy habits, these compounds supports long-term success and weight maintenance.
Choose a treatment plan that fits your needs and complete an online health history form to kickstart your personalized care.
A licensed medical professional will evaluate your intake form to determine the right plan for you.
If prescribed, your medication will be shipped to your door in discreet packaging, with free, fast delivery.
Stay connected with your healthcare provider for continuous support and care, ensuring your health journey stays on track.
Find answers to common questions about our medication subscriptions and medical review process.
Wegovy works by mimicking the hormone GLP-1, which slows digestion and helps your brain regulate appetite by reducing hunger sensations. As your digestion slows, you may feel full longer and therefore eat less, which can lead to weight loss.
Where diet and exercise alone might have failed you long-term, Wegovy could be the missing piece of the puzzle for you, as it is for many people.
In one of the most significant clinical trials on Wegovy, participants who took Wegovy combined with lifestyle interventions (lowering food intake and increasing physical activity) lost an average of 15% of their body weight by the end of the 68-week trial. In comparison, the placebo group lost less than 2.5% of their body weight on average with just lifestyle interventions (Wilding, 2021).
What’s most impressive is these results appear to have long-term effectiveness, as long as a person continues taking the drug. One study showed that, over the course of 68 weeks, those who continued taking Wegovy kept losing weight, while those who were switched to placebo at week 20 saw an average of 8% weight gain by the end of the trial (Rubino, 2021).
That’s probably the biggest key, though. To see long-term results from Wegovy, you have to keep taking it. It works very well for most people, but if you stop taking it, you should expect to gain back the weight you lost.
It helps to recognize that obesity and overweight are medical conditions, much like high blood pressure. A person with high blood pressure needs to keep taking their medicine to keep their blood pressure down—and the same idea applies to treating overweight and obesity with Wegovy.
Wegovy dosing starts out low, then gradually increases over the first few months until a steady dose is reached. If prescribed, your Good Life-affiliated provider will work with you to find the schedule and dosing that’s right for you. As an example, your provider may start you out on the lowest dose, 0.25 mg injected once weekly for the first month and slowly ramp you up to the maximum dose of 2.4 mg once weekly over the course of several months. This will depend upon your specific situation and your provider’s guidance.
In clinical trials, patients lost 15% of their body weight after 1 year, on average. This is based on the average weight loss in the three 68-week clinical trials of patients without diabetes who reached and maintained a dose of 2.4 mg/week of GLP-1 treatment, along with a reduced-calorie diet and increased physical activity.
In the STEP 4 clinical trial, people who combined Wegovy with a healthy diet and exercise lost an average of over 4% of their body weight by eight weeks. Those who reached a steady dose of 2.4 mg per week lost an average of 10.6% of their body weight in the first 20 weeks of treatment—and over 17% of their body weight within 68 weeks. Everyone responds to Wegovy differently, and if prescribed, your Good Life-affiliated provider will work with you to get the best results for you.
Achieving and maintaining weight loss isn’t solely aboutwillpower or modifying your diet and exercise habits. Biological factors andgenetics also significantly influence the process. If you’ve faced challengeswith weight loss previously, consider seeking assistance from weight lossmedications.
Here are three reasons why weight loss efforts might falter: